All Title Author
Keywords Abstract

PLOS ONE  2013 

Association between Plasma Neutrophil Gelatinase Associated Lipocalin Level and Obstructive Sleep Apnea or Nocturnal Intermittent Hypoxia

DOI: 10.1371/journal.pone.0054184

Full-Text   Cite this paper   Add to My Lib


Background Both obstructive sleep apnea (OSA) and a novel lipocalin, neutrophil gelatinase associated lipocalin (Ngal), have been reported to be closely linked with cardiovascular disease and loss of kidney function through chronic inflammation. However, the relationship between OSA and Ngal has never been investigated. Objectives To evaluate the relationship between Ngal and OSA in clinical practice. Methods In 102 patients, polysomnography was performed to diagnose OSA and plasma Ngal levels were measured. The correlations between Ngal levels and OSA severity and other clinical variables were evaluated. Of the 46 patients who began treatment with continuous positive airway pressure (CPAP), Ngal levels were reevaluated after three months of treatment in 25 patients. Results The Ngal level correlated significantly with OSA severity as determined by the apnea hypopnea index (r = 0.24, p = 0.01) and 4% oxygen desaturation index (ODI) (r = 0.26, p = 0.01). Multiple regression analysis showed that the Ngal level was associated with 4%ODI independently of other clinical variables. Compliance was good in 13 of the 25 patients who used CPAP. Although the OSA (4%ODI: 33.1±16.7 to 1.1±1.9/h, p<0.01) had significantly improved in those with good compliance, the Ngal levels were not significantly changed (60.5±18.1 before CPAP vs 64.2±13.9 ng/ml after CPAP, p = 0.27). Conclusions Plasma Ngal levels were positively associated with the severity of OSA. However, the contribution rate of OSA to systemic Ngal secretion was small and changes in Ngal levels appeared to be influenced largely by other confounding factors. Therefore, it does not seem reasonable to use the Ngal level as a specific biomarker of OSA in clinical practice.


[1]  Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N (1993) Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. The Journal of Biological Chemistry 268: 10425–10432.
[2]  Bao G, Clifton M, Hoette TM, Mori K, Deng SX, et al. (2010) Iron traffics in circulation bound to a siderocalin (ngal)-catechol complex. Nature Chemical Biology 6: 602–609. 10.1038/nchembio.402.
[3]  Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, et al. (2003) Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. Journal of the American Society of Nephrology : JASN 14: 2534–2543.
[4]  Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, et al. (2005) Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365: 1231–1238. 10.1016/S0140–6736(05)74811-X.
[5]  Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, et al. (2005) Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. The Journal of Clinical Investigation 115: 610–621. 10.1172/JCI23056.
[6]  Bolignano D, Lacquaniti A, Coppolino G, Donato V, Campo S, et al. (2009) Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clinical Journal of the American Society of Nephrology : CJASN 4: 337–344. 10.2215/CJN.03530708.
[7]  Viau A, El Karoui K, Laouari D, Burtin M, Nguyen C, et al. (2010) Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. The Journal of Clinical Investigation 120 4065–4076: 10.1172/JCI42004.
[8]  Hemdahl AL, Gabrielsen A, Zhu C, Eriksson P, Hedin U, et al. (2006) Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arteriosclerosis, Thrombosis, and Vascular Biology 26: 136–142. 10.1161/01.ATV.0000193567.88685.f4.
[9]  Yndestad A, Landro L, Ueland T, Dahl CP, Flo TH, et al. (2009) Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure. European Heart Journal 30: 1229–1236. 10.1093/eurheartj/ehp088.
[10]  Daniels LB, Barrett-Connor E, Clopton P, Laughlin GA, Ix JH, et al. (2012) Plasma neutrophil gelatinase-associated lipocalin is independently associated with cardiovascular disease and mortality in community-dwelling older adults: The rancho bernardo study. Journal of the American College of Cardiology 59: 1101–1109. 10.1016/j.jacc.2011.11.046.
[11]  Young T, Palta M, Dempsey J, Skatrud J, Weber S, et al. (1993) The occurrence of sleep-disordered breathing among middle-aged adults. The New England Journal of Medicine 328: 1230–1235. 10.1056/NEJM199304293281704.
[12]  Punjabi NM (2008) The epidemiology of adult obstructive sleep apnea. Proceedings of the American Thoracic Society 5: 136–143. 10.1513/pats.200709–155MG.
[13]  Nakayama-Ashida Y, Takegami M, Chin K, Sumi K, Nakamura T, et al. (2008) Sleep-disordered breathing in the usual lifestyle setting as detected with home monitoring in a population of working men in japan. Sleep 31: 419–425.
[14]  Kohler M, Stradling JR (2010) Mechanisms of vascular damage in obstructive sleep apnea. Nature Reviews.Cardiology 7: 677–685. 10.1038/nrcardio.2010.145.
[15]  Drager LF, Polotsky VY, Lorenzi-Filho G (2011) Obstructive sleep apnea: An emerging risk factor for atherosclerosis. Chest 140: 534–542. 10.1378/chest.10–2223.
[16]  Nicholl DD, Ahmed SB, Loewen AH, Hemmelgarn BR, Sola DY, et al. (2012) Declining kidney function increases the prevalence of sleep apnea and nocturnal hypoxia. Chest 141: 1422–1430. 10.1378/chest.11–1809.
[17]  Ahmed SB, Ronksley PE, Hemmelgarn BR, Tsai WH, Manns BJ, et al. (2011) Nocturnal hypoxia and loss of kidney function. PloS One 6: e19029. 10.1371/journal.pone.0019029.
[18]  Ryan S, Taylor CT, McNicholas WT (2005) Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112: 2660–2667. 10.1161/CIRCULATIONAHA.105.556746.
[19]  Liu Q, Nilsen-Hamilton M (1995) Identification of a new acute phase protein. The Journal of Biological Chemistry 270: 22565–22570.
[20]  Jayaraman A, Roberts KA, Yoon J, Yarmush DM, Duan X, et al. (2005) Identification of neutrophil gelatinase-associated lipocalin (NGAL) as a discriminatory marker of the hepatocyte-secreted protein response to IL-1beta: A proteomic analysis. 91: 502–515.
[21]  Wallenius V, Elias E, Bergstrom GM, Zetterberg H, Behre CJ (2011) The lipocalins retinol-binding protein-4, lipocalin-2 and lipocalin-type prostaglandin D2-synthase correlate with markers of inflammatory activity, alcohol intake and blood lipids, but not with insulin sensitivity in metabolically healthy 58-year-old swedish men. Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association 119: 75–80. 10.1055/s–0030–1265212.
[22]  Yan QW, Yang Q, Mody N, Graham TE, Hsu CH, et al. (2007) The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes 56: 2533–2540. 10.2337/db07–0007.
[23]  Choi KM, Kim TN, Yoo HJ, Lee KW, Cho GJ, et al. (2009) Effect of exercise training on A-FABP, lipocalin-2 and RBP4 levels in obese women. Clinical Endocrinology 70: 569–574. 10.1111/j.1365?2265.2008.03374.x.
[24]  Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Washington, DC: National Institutes of Health.
[25]  Iber C, Ancoli-Israel S, Chesson A, Quan S (2007) The AASM manual for the scoring of sleep and associated events: Rules, terminology and technical specifications. Westchester, IL, USA: American Academy of Sleep Medicine.
[26]  Collen J, Lettieri C, Kelly W, Roop S (2009) Clinical and polysomnographic predictors of short-term continuous positive airway pressure compliance. Chest 135: 704–709. 10.1378/chest.08–2182.
[27]  Niigaki M, Adachi K, Hirakawa K, Furuta K, Kinoshita Y (2012) Association between metabolic syndrome and prevalence of gastroesophageal reflux disease in a health screening facility in japan. Journal of Gastroenterology. 10.1007/s00535-012-0671-3.
[28]  Jiang W, Constante M, Santos MM (2008) Anemia upregulates lipocalin 2 in the liver and serum. Blood Cells, Molecules & Diseases 41: 169–174. 10.1016/j.bcmd.2008.04.006.
[29]  Makino S, Fujiwara M, Suzukawa K, Handa H, Fujie T, et al. (2009) Visceral obesity is associated with the metabolic syndrome and elevated plasma retinol binding protein-4 level in obstructive sleep apnea syndrome. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme 41: 221–226. 10.1055/s–0028–1100411.
[30]  Nena E, Steiropoulos P, Tzouvelekis A, Tsara V, Hatzizisi O, et al. (2010) Reduction of serum retinol-binding protein-4 levels in nondiabetic obstructive sleep apnea patients under continuous positive airway pressure treatment. Respiration; International Review of Thoracic Diseases 80: 517–523. 10.1159/000295903.
[31]  Wang Y, Lam KS, Kraegen EW, Sweeney G, Zhang J, et al. (2007) Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clinical Chemistry 53: 34–41. 10.1373/clinchem.2006.075614.
[32]  Liu X, Hamnvik OP, Petrou M, Gong H, Chamberland JP, et al. (2011) Circulating lipocalin 2 is associated with body fat distribution at baseline but is not an independent predictor of insulin resistance: The prospective cyprus metabolism study. European Journal of Endocrinology/European Federation of Endocrine Societies 165: 805–812. 10.1530/EJE–11–0660.
[33]  Fassett RG, Robertson IK, Ball MJ, Geraghty DP, Cardinal JW, et al. (2012) Effects of atorvastatin on NGAL and cystatin C in chronic kidney disease: A post hoc analysis of the LORD trial. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association 27: 182–189. 10.1093/ndt/gfr193.
[34]  Ronco C (2007) N-GAL: Diagnosing AKI as soon as possible. Critical Care (London, England) 11: 173. 10.1186/cc6162.
[35]  Giaginis C, Zira A, Katsargyris A, Klonaris C, Theocharis S (2010) Clinical implication of plasma neutrophil gelatinase-associated lipocalin (NGAL) concentrations in patients with advanced carotid atherosclerosis. Clinical Chemistry and Laboratory Medicine : CCLM/FESCC 48: 1035–1041. 10.1515/CCLM.2010.211.


comments powered by Disqus